U.S. Pharmaceutical Contract Development & Manufacturing Organization Market (2025 - 2033) Size, Share & Trends Analysis Report By Type, By Product, By Services, By Workflow, By Therapeutic Area, By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Research Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Type
                       1.2.2. Product
                       1.2.3. Services
                       1.2.4. Workflow
                       1.2.5. Therapeutic Area
                       1.2.6. End Use
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased Database
                       1.4.2. GVR’s Internal Database
                       1.4.3. Secondary Sources
                       1.4.4. Primary Research
                   1.5. Information Or Data Analysis
                       1.5.1. Data Analysis Models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity Flow Analysis
                       1.7.2. Top-Down Analysis
                       1.7.3. Botton-Up Approach
                       1.7.4. Multivariate Analysis
                   1.8. List Of Secondary Sources
                   1.9. List Of Abbreviations
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                       3.2.2. Market Restraint Analysis
                       3.2.3. Market Opportunity Analysis
                   3.3. R&D Spending Analysis
                   3.4. Industry Ecosystem Analysis
                       3.4.1. Demand Analysis
                       3.4.2. Supply Chain Analysis
                   3.5. Technology Landscape
                   3.6. Clinical Trial Volume Analysis, 2024
                   3.7. Pricing Analysis
                   3.8. Tariff and Trade Agreement Impact Analysis
                   3.9. Value Chain Analysis
                       3.9.1. Supply Trends
                       3.9.2. Demand Trends
                   3.10. Market Analysis Tools
                       3.10.1. Porter’s Five Forces Analysis
                       3.10.2. PESTEL by SWOT Analysis
Chapter 4. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Type Estimates & Trend Analysis
                   4.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Type: Segment Dashboard
                   4.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Type: Movement Analysis
                   4.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
                   4.4. Small Molecule
                       4.4.1. Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       4.4.2. Branded
                           4.4.2.1. Branded Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       4.4.3. Generic
                           4.4.3.1. Generic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   4.5. Large Molecule
                       4.5.1. Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       4.5.2. Biologics
                           4.5.2.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       4.5.3. Biosimilar
                           4.5.3.1. Biosimilar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Product Estimates & Trend Analysis
                   5.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Product: Segment Dashboard
                   5.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Product: Movement Analysis
                   5.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
                   5.4. API
                       5.4.1. API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.4.2. Traditional Active Pharmaceutical Ingredient (Traditional API)
                           5.4.2.1. Traditional Active Pharmaceutical Ingredient (Traditional API) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.4.3. Highly Potent Active Pharmaceutical Ingredient (HP-API)
                           5.4.3.1. Highly Potent Active Pharmaceutical Ingredient (HP-API) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.4.4. Biologics
                           5.4.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.4.5. Others
                           5.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   5.5. Drug Product
                       5.5.1. Drug Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.5.2. Oral Solid Dose
                           5.5.2.1. Oral Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.5.3. Semi-Solid Dose
                           5.5.3.1. Semi-Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.5.4. Liquid Dose
                           5.5.4.1. Liquid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       5.5.5. Others
                           5.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Service Estimates & Trend Analysis
                   6.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Service: Segment Dashboard
                   6.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Service: Movement Analysis
                   6.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
                   6.4. Contract Development
                       6.4.1. Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.4.2. Pre-formulation & Formulation Development Services
                           6.4.2.1. Pre-formulation & Formulation Development Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.4.3. Process Development & Optimization
                           6.4.3.1. Process Development & Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.4.4. Analytical Testing & Method Validation
                           6.4.4.1. Analytical Testing & Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.4.5. Scale-up & Tech Transfer
                           6.4.5.1. Scale-up & Tech Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   6.5. Contract Manufacturing
                       6.5.1. Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.5.2. API Manufacturing
                           6.5.2.1. API Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.5.3. Finished Drug Products Manufacturing
                           6.5.3.1. Finished Drug Products Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   6.6. Packaging and Labelling
                       6.6.1. Packaging and Labelling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   6.7. Regulatory Affairs
                       6.7.1. Regulatory Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   6.8. Others
                       6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Workflow Estimates & Trend Analysis
                   7.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Workflow: Segment Dashboard
                   7.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Workflow: Movement Analysis
                   7.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
                   7.4. Clinical
                       7.4.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.5. Commercial
                       7.5.1. Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Therapeutic Area Estimates & Trend Analysis
                   8.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Therapeutic Area: Segment Dashboard
                   8.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By Therapeutic Area: Movement Analysis
                   8.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million)
                   8.4. Oncology
                       8.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.5. Infectious Diseases
                       8.5.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.6. Neurological Disorders
                       8.6.1. Neurological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.7. Cardiovascular Diseases
                       8.7.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.8. Metabolic Disorders
                       8.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.9. Autoimmune Diseases
                       8.9.1. Autoimmune Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.10. Respiratory Diseases
                       8.10.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.11. Ophthalmology
                       8.11.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.12. Gastrointestinal Disorders
                       8.12.1. Gastrointestinal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.13. Orthopedic Diseases
                       8.13.1. Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.14. Dental Diseases
                       8.14.1. Dental Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.15. Others
                       8.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: End Use Estimates & Trend Analysis
                   9.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By End Use: Segment Dashboard
                   9.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, By End Use: Movement Analysis
                   9.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
                   9.4. Small Pharmaceutical Companies
                       9.4.1. Small Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   9.5. Medium Pharmaceutical Companies
                       9.5.1. Medium Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   9.6. Large Pharmaceutical Companies
                       9.6.1. Large Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
                   10.1. Key Participant Categorization
                       10.1.1. Market Leaders
                       10.1.2. Emerging Players
                   10.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
                   10.3. Company Profiles
                       10.3.1. Thermo Fisher Scientific, Inc
                           10.3.1.1. Company Overview
                           10.3.1.2. Financial Performance
                           10.3.1.3. Service Benchmarking
                           10.3.1.4. Strategic Initiatives
                       10.3.2. Lonza
                           10.3.2.1. Company Overview
                           10.3.2.2. Financial Performance
                           10.3.2.3. Service Benchmarking
                           10.3.2.4. Strategic Initiatives
                       10.3.3. Recipharm AB
                           10.3.3.1. Company Overview
                           10.3.3.2. Financial Performance
                           10.3.3.3. Service Benchmarking
                           10.3.3.4. Strategic Initiatives
                       10.3.4. Catalent, Inc
                           10.3.4.1. Company Overview
                           10.3.4.2. Financial Performance
                           10.3.4.3. Service Benchmarking
                           10.3.4.4. Strategic Initiatives
                       10.3.5. WuXi AppTec, Inc
                           10.3.5.1. Company Overview
                           10.3.5.2. Financial Performance
                           10.3.5.3. Service Benchmarking
                           10.3.5.4. Strategic Initiatives
                       10.3.6. Samsung Biologics
                           10.3.6.1. Company Overview
                           10.3.6.2. Financial Performance
                           10.3.6.3. Service Benchmarking
                           10.3.6.4. Strategic Initiatives
                       10.3.7. Piramal Pharma Solutions
                           10.3.7.1. Company Overview
                           10.3.7.2. Financial Performance
                           10.3.7.3. Service Benchmarking
                           10.3.7.4. Strategic Initiatives
                       10.3.8. Siegfried Holding AG
                           10.3.8.1. Company Overview
                           10.3.8.2. Financial Performance
                           10.3.8.3. Service Benchmarking
                           10.3.8.4. Strategic Initiatives
                       10.3.9. Corden Pharma International
                           10.3.9.1. Company Overview
                           10.3.9.2. Financial Performance
                           10.3.9.3. Service Benchmarking
                           10.3.9.4. Strategic Initiatives
                       10.3.10. Cambrex Corporation
                           10.3.10.1. Company Overview
                           10.3.10.2. Financial Performance
                           10.3.10.3. Service Benchmarking
                           10.3.10.4. Strategic Initiatives
                       10.3.11. Vetter Pharma
                           10.3.11.1. Company Overview
                           10.3.11.2. Financial Performance
                           10.3.11.3. Service Benchmarking
                           10.3.11.4. Strategic Initiatives
                       10.3.12. Delpharm
                           10.3.12.1. Company Overview
                           10.3.12.2. Financial Performance
                           10.3.12.3. Service Benchmarking
                           10.3.12.4. Strategic Initiatives
                       10.3.13. Jubilant Pharmova / HollisterStier
                           10.3.13.1. Company Overview
                           10.3.13.2. Financial Performance
                           10.3.13.3. Service Benchmarking
                           10.3.13.4. Strategic Initiatives
                       10.3.14. Eurofins CDMO
                           10.3.14.1. Company Overview
                           10.3.14.2. Financial Performance
                           10.3.14.3. Service Benchmarking
                           10.3.14.4. Strategic Initiatives
                       10.3.15. Almac Pharma Services
                           10.3.15.1. Company Overview
                           10.3.15.2. Financial Performance
                           10.3.15.3. Service Benchmarking
                           10.3.15.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
Table 4 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 5 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 6 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 7 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
Table 8 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Type outlook and key takeaways
Fig. 20 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Type movement analysis
Fig. 21 Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Branded Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 Generic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 24 Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 25 Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 26 Biosimilar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 27 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Product outlook and key takeaways
Fig. 28 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Product movement analysis
Fig. 29 Pharmaceutical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 30 API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 31 Traditional API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 32 HP-API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 33 Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 35 Drug Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 36 Oral Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 37 Semi-Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 38 Liquid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 39 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Service outlook and key takeaways
Fig. 41 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Service movement analysis
Fig. 42 Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 43 Pre-formulation & Formulation Development Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 44 Process Development & Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Analytical Testing & Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 46 Scale-up & Tech Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 48 API Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 Finished Drug Products Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 50 Packaging and Labelling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 51 Regulatory Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 52 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 53 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Workflow outlook and key takeaways
Fig. 54 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Workflow movement analysis
Fig. 55 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 56 Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 57 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Therapeutic Area outlook and key takeaways
Fig. 58 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Therapeutic Area movement analysis
Fig. 59 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 60 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 61 Neurological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 62 Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 63 Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 64 Autoimmune Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 65 Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 66 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 67 Gastrointestinal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 68 Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 69 Dental Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 70 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 71 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: End Use outlook and key takeaways
Fig. 72 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: End Use movement analysis
Fig. 73 Small Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 74 Medium Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 75 Large Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 76 Key company categorization
Fig. 77 Service heat map analysis
Fig. 78 Strategic framework